Alain is a Venture Partner of Lightstone Ventures. He serves in a similar role at Morgenthaler Ventures, where he began his affiliation with the firm in 2008. Based in San Diego, he is Founder and CEO of Elcelyx, a Morgenthaler portfolio company in the diabetes/obesity space.
Prior to his role at Morgenthaler, Alain was Senior Vice President of Research at Amylin Pharmaceuticals, where he served in senior roles in R&D since 1999. Previously, Alain worked at Indiana University School of Medicine in Indianapolis, where he served as Professor Medicine and Director, Division of Endocrinology and Metabolism. He also has held faculty positions in the Division of endocrinology and Metabolism at University of California, San Diego, and the Veterans Administration Medical Center in San Diego. Alain is the recipient of several prestigious awards for his research in diabetes and vascular disease, including the 1996 Outstanding Clinical Investigator Award from the American Federation for Medical Research. He is also a past National Institutes of Health MERIT award recipient. He is Co-Editor of the Ellenberg & Rifkin Textbook of Diabetes. He has authored more than 100 original publications and is an inventor on more than 20 patents. Alain received a B.S. in Biology with honors from McGill University (Canada), an M.D. from Medical College of Georgia Augusta, and completed postdoctoral studies at the University of California, San Diego.